Pharmaceutical group · United States
Purdue
A group of 4 companies with 130 medicines in 3 countries.
Group structure
4 companies in 2 countries
United States2
Canada1
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
1–25 of 130
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BUTRANS 1010 mcg / hour · Patch | Buprenorphine | Canada | Marketed | 2010 |
| BUTRANS 1515 mcg / hour · Patch | Buprenorphine | Canada | Marketed | 2016 |
| BUTRANS 2020 mcg / hour · Patch | Buprenorphine | Canada | Marketed | 2010 |
| BUTRANS 55 mcg / hour · Patch | Buprenorphine | Canada | Marketed | 2010 |
| CHIROCAINE2.5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 7.5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Levobupivacaine | United States | Not marketed | 1999 |
| CODEINE CONTIN 100MG CONTROLLED RELEASE TAB100 mg · Tablet (Extended-Release) | Codeine | Canada | Marketed | 1995 |
| CODEINE CONTIN 150MG CONTROLLED RELEASE TAB150 mg · Tablet (Extended-Release) | Codeine | Canada | Marketed | 1995 |
| CODEINE CONTIN 200MG CONTROLLED RELEASE TAB200 mg · Tablet (Extended-Release) | Codeine | Canada | Marketed | 1995 |
| CODEINE CONTIN 50MG CONTROLLED RELEASE TAB50 mg · Tablet (Extended-Release) | Codeine | Canada | Marketed | 1997 |
| DILAUDID2 mg · Tablet | Hydromorphone | Canada | Marketed | 1984 |
| DILAUDID8 mg · Tablet | Hydromorphone | Canada | Marketed | 1989 |
| DILAUDID1 mg · Tablet | Hydromorphone | Canada | Marketed | 1986 |
| DILAUDID4 mg · Tablet | Hydromorphone | Canada | Marketed | 1984 |
| HYDROMORPH CONTIN4.5 mg · Capsule (Sustained-Release) | Hydromorphone | Canada | Marketed | 2011 |
| HYDROMORPH CONTIN9 mg · Capsule (Sustained-Release) | Hydromorphone | Canada | Marketed | 2011 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG12 mg · Capsule (Sustained-Release) | Hydromorphone | Canada | Marketed | 1996 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG18 mg · Capsule (Sustained-Release) | Hydromorphone | Canada | Marketed | 2001 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG24 mg · Capsule (Sustained-Release) | Hydromorphone | Canada | Marketed | 1996 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG30 mg · Capsule (Sustained-Release) | Hydromorphone | Canada | Marketed | 1998 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG3 mg · Capsule (Sustained-Release) | Hydromorphone | Canada | Marketed | 1995 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG6 mg · Capsule (Sustained-Release) | Hydromorphone | Canada | Marketed | 1995 |
| INTERMEZZO1.75mg | 3.5mg · Tablet | Zolpidem | United States | Not marketed | 2011 |
| MS CONTIN15 mg · Tablet (Extended-Release) | Morphine | Canada | Marketed | 1993 |
| MS CONTIN30 mg · Tablet (Extended-Release) | Morphine | Canada | Marketed | 1993 |
| MS CONTIN100 mg · Tablet (Extended-Release) | Morphine | Canada | Marketed | 1993 |